Tripartite Therapeutics Inc. Share Price

Stocks

7920

TW0007920001

Biotechnology & Medical Research

End-of-day quote 14/08/2026 5-day change 1st Jan Change
8.050 TWD +0.63% Intraday chart for Tripartite Therapeutics Inc. -0.86% -
1 week-0.86%
Current month-2.42%
1 day+0.63%
1 week-0.86%
Current month-2.42%
1 month-21.84%
1 week 7.47
Extreme 7.47
8.4
1 month 7.47
Extreme 7.47
12.2
Current year 5.91
Extreme 5.91
20.6
1 year 5.91
Extreme 5.91
20.6
3 years 5.91
Extreme 5.91
20.6
5 years 5.91
Extreme 5.91
20.6
10 years 5.91
Extreme 5.91
20.6
Manager TitleAgeSince
Chief Executive Officer - 02/03/2015
Director of Finance/CFO - 07/08/2024
Chief Tech/Sci/R&D Officer - 20/06/2016
Director TitleAgeSince
Chairman - 02/03/2015
Director/Board Member - 31/07/2015
Director/Board Member - 22/08/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%-0.86% - - 149M
-1.90%+2.85%+61.37%+102.88% 70.07B
-3.21%-4.32%+31.19%+59.75% 52.87B
-2.05%-5.61%-3.14%+454.89% 27.02B
-1.27%-1.57%+46.46%+6.09% 23.61B
+1.05%-0.62%-17.40%-13.36% 23.38B
+3.81%+20.97%+263.48%+552.47% 19.43B
+0.10%+1.40%+38.98%-20.04% 18.75B
-0.95%-3.52%+20.04%+613.01% 15.85B
+1.24%-5.23%+33.19%+138.21% 12.7B
Average -0.26%+1.94%+52.69%+210.43% 26.38B
Weighted average by Cap. -1.09%+0.56%+49.85%+168.09%
Logo Tripartite Therapeutics Inc.
Tripartite Therapeutics Inc is a Taiwan-based company mainly engaged in the development of hydrophilic platform technologies for antibody drug conjugate (ADC) and new drug research and development. It provides ADC design services and subsequent licensing through OmniLink linker technology and Polarpeutic hydrophilic payload modification technology. Its main product is the antibody polar drug conjugate (APDC) developed using the patented OmniLink technology. This APDC consists of the cytotoxic maytansinoid drug conjugated to the trastuzumab antibody. It is used for the drug treatment of various solid tumors such as breast cancer, lung cancer, and gastric cancer. It primarily provides products and services in Taiwan.
Employees
-
Date Price Change Volume
14/08/26 NT$8.050 +0.63% 691,150
13/08/26 NT$8.000 -3.61% 774,818
12/08/26 NT$8.300 +5.06% 1,194,037
11/08/26 NT$7.900 0.00% 2,438,241
10/08/26 NT$7.900 -2.71% 3,085,453
  1. Stock Market
  2. Stocks
  3. 7920 Stock